Search

Your search keyword '"Gimenez R."' showing total 270 results
Start Over Author "Gimenez R."
270 results on '"Gimenez R."'

2. Compliance Evaluation of WTG and WPP Controllers for Self and Black Start Operation

Author

Martínez-Turégano, J., Anó~-Villalba, S., Bernal-Perez, S., Blasco-Gimenez, R., Angrisani, Leopoldo, Series Editor, Arteaga, Marco, Series Editor, Panigrahi, Bijaya Ketan, Series Editor, Chakraborty, Samarjit, Series Editor, Chen, Jiming, Series Editor, Chen, Shanben, Series Editor, Chen, Tan Kay, Series Editor, Dillmann, Rüdiger, Series Editor, Duan, Haibin, Series Editor, Ferrari, Gianluigi, Series Editor, Ferre, Manuel, Series Editor, Hirche, Sandra, Series Editor, Jabbari, Faryar, Series Editor, Jia, Limin, Series Editor, Kacprzyk, Janusz, Series Editor, Khamis, Alaa, Series Editor, Kroeger, Torsten, Series Editor, Li, Yong, Series Editor, Liang, Qilian, Series Editor, Martín, Ferran, Series Editor, Ming, Tan Cher, Series Editor, Minker, Wolfgang, Series Editor, Misra, Pradeep, Series Editor, Möller, Sebastian, Series Editor, Mukhopadhyay, Subhas, Series Editor, Ning, Cun-Zheng, Series Editor, Nishida, Toyoaki, Series Editor, Oneto, Luca, Series Editor, Pascucci, Federica, Series Editor, Qin, Yong, Series Editor, Seng, Gan Woon, Series Editor, Speidel, Joachim, Series Editor, Veiga, Germano, Series Editor, Wu, Haitao, Series Editor, Zamboni, Walter, Series Editor, Zhang, Junjie James, Series Editor, Pierfederici, Serge, editor, and Martin, Jean-Philippe, editor

Published
2023
Full Text
View/download PDF

9. Spatial variability of the relationships of runoff and sediment yield with weather types throughout the Mediterranean basin

Author

Peña-Angulo, D., Nadal-Romero, E., González-Hidalgo, J.C., Albaladejo, J., Andreu, V., Bagarello, V., Barhi, H., Batalla, R.J., Bernal, S., Bienes, R., Campo, J., Campo-Bescós, M.A., Canatario-Duarte, A., Cantón, Y., Casali, J., Castillo, V., Cerdà, A., Cheggour, A., Cid, P., Cortesi, N., Desir, G., Díaz-Pereira, E., Espigares, T., Estrany, J., Fernández-Raga, M., Ferreira, C.S.S., Ferro, V., Gallart, F., Giménez, R., Gimeno, E., Gómez, J.A., Gómez-Gutiérrez, A., Gómez-Macpherson, H., González-Pelayo, O., Hueso-González, P., Kairis, O., Karatzas, G.P., Klotz, S., Kosmas, C., Lana-Renault, N., Lasanta, T., Latron, J., Lázaro, R., Le Bissonnais, Y., Le Bouteiller, C., Licciardello, F., López-Tarazón, J.A., Lucía, A., Marín, C., Marqués, M.J., Martínez-Fernández, J., Martínez-Mena, M., Martínez-Murillo, J.F., Mateos, L., Mathys, N., Merino-Martín, L., Moreno-de las Heras, M., Moustakas, N., Nicolau, J.M., Novara, A., Pampalone, V., Raclot, D., Rodríguez-Blanco, M.L., Rodrigo-Comino, J., Romero-Díaz, A., Roose, E., Rubio, J.L., Ruiz-Sinoga, J.D., Schnabel, S., Senciales-González, J.M., Simonneaux, V., Solé-Benet, A., Taguas, E.V., Taboada-Castro, M.M., Taboada-Castro, M.T., Todisco, F., Úbeda, X., Varouchakis, E.A., Vericat, D., Wittenberg, L., Zabaleta, A., and Zorn, M.

Published
2019
Full Text
View/download PDF

18. Steady-state power distribution in VSC-based MTDC systems and dc grids under mixed P/V and I/V droop control

Author

Sun, P, Wang, Y, Khalid, M, Blasco-Gimenez, R, Konstantinou, G, Sun, P, Wang, Y, Khalid, M, Blasco-Gimenez, R, and Konstantinou, G

Abstract

This paper proposes a steady-state power distribution derivation method for voltage source converter (VSC)-based multi-terminal HVDC (MTDC) systems and dc grids under mixed power/voltage (P/V) and current/voltage (I/V) droop control. P/V and I/V droop control are two commonly used control schemes, which can be combined to achieve co-regulation of powers & currents in MTDC systems and dc grids. The proposed method can be used to estimate the power distributions under different scenarios for MTDC systems and dc grids based on VSCs with mixed P/V and I/V droop control. After determining the initial operating point based on an estimation-correction algorithm, redistributed power due to power disturbances, current changes or converter outages is analyzed in detail considering converter overload. An excess power reduction strategy is further proposed to avoid violation of power limits after converter outage. The accuracy of the proposed method is validated through multiple scenarios in a modular multilevel converter (MMC)-based four-terminal dc grid. The comparison between the proposed method and other approaches in the current literature further demonstrates the advantages of proposed power distribution derivation method.

Published
2023

26. Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: The VISIONARY Study

Author

Oddone, F., Tanga, L., Kothy, P., Hollo, G., Faschinger, C., Chen, E., Nemeth, G., Bator, G., Tsorbatzoglou, A., Acs, T., Ferencz, M., Sohajda, Z., Toth, J., Volner, V., Vogt, G., Biro, Z., Facsko, A., Nemes, J., Berta, A., Elek, I., Ng, E., Rossi, G., Rossetti, L., Vetrugno, M., Iester, M., Marchini, G., Scorcia, V., Staurenghi, G., Cagini, C., Salgarello, T., Bettin, P., Figus, M., Scuderi, G. L., De Cilla, S., Grundmane, I., Linavska, N., Volksone, L., Laganovska, G., Baumane, K., Lemij, H., Gundersen, K. G., Zimina, M., Erichev, V., Karlova, E., Zakharova, E., Panova, I., Malyugin, B., Aguirrec, I. R., Lopez-Lopez, F., Valladares, A. M., del Castillo, J. B., Gimenez, R., Vallejo, M. P., Medina, J. G., Lopez, A. A., Torregrosa, S., Loscos, J., Kolko, M., Ansari, E., Broadway, D., Claridge, K., Ruben, S., Kirwan, J., Nita, A., Smith, M., Moosavi, A., King, A. J. W., and Kinsella, M.

Subjects
Male, 030213 general clinical medicine, Intraocular pressure, genetic structures, Ocular hypertension, Timolol, Glaucoma, 0302 clinical medicine, Prostaglandins, Synthetic, Medicine, Pharmacology (medical), Prospective Studies, Open-angle glaucoma, media_common, Original Research, Aged, 80 and over, Fixed-dose combination, General Medicine, Middle Aged, Drug Combinations, Tolerability, 030220 oncology & carcinogenesis, Female, Glaucoma, Open-Angle, medicine.drug, medicine.medical_specialty, medicine.drug_class, Tonometry, Ocular, 03 medical and health sciences, Preservative-free topical medication, Ophthalmology, Humans, media_common.cataloged_instance, European union, Antihypertensive Agents, Intraocular Pressure, Aged, business.industry, Preservatives, Pharmaceutical, Prostaglandins F, Tafluprost, Correction, medicine.disease, eye diseases, sense organs, Prostaglandin analogue, business
Abstract

Introduction: A non-interventional, multicenter, European, prospective evaluation of the effectiveness, tolerability, and safety of a topical preservative-free tafluprost (0.0015%) and timolol (0.5%) fixed-dose combination (PF tafluprost/timolol FC) in adults with open-angle glaucoma (OAG) and ocular hypertension (OHT) demonstrating insufficient response to topical beta-receptor blockers or prostaglandin analogue (PGA) monotherapy. Methods: Mean intraocular pressure (IOP) change from baseline was measured at study visits following a switch to PF tafluprost/timolol FC. Primary endpoint was absolute mean IOP change at month 6. Change from baseline concerning ocular signs and symptoms was also explored. Results: Analyses included 577 patients (59.6% female). Mean age (SD) was 67.8 (11.67) years. Mean (SD) IOP reduction from baseline was significant at all study visits; 5.4 (3.76) mmHg (23.7%) at week 4, 5.9 (3.90) mmHg (25.6%) at week 12, and 5.7 (4.11) mmHg (24.9%) at month 6 (p < 0.0001 for all visits). At month 6, 69.2%, 53.6%, 40.0%, and 25.8% were responders based on ≥ 20%, ≥ 25%, ≥ 30%, and ≥ 35% cutoff values for mean IOP, respectively. Significant reductions were observed concerning corneal fluorescein staining (p < 0.0001), dry eye symptoms, irritation, itching, and foreign body sensation (p < 0.001 for each parameter). Conjunctival hyperemia was significantly reduced at all study visits (p < 0.0001 at each visit). Overall, 69 treatment-related adverse events (AEs) were reported, one of which was serious (status asthmaticus). Most AEs were mild to moderate in severity, and the majority had resolved or were resolving at the end of the study period. Conclusion: In clinical practice, PF tafluprost/timolol FC provided statistically and clinically significant IOP reductions in patients with OAG and OHT insufficiently controlled on or intolerant to PGA or beta-receptor blocker monotherapy. The full IOP reduction appeared at week 4 and was maintained over the 6-month study period. Key symptoms of ocular surface health improved. Trial Registration: European Union electronic Register of Post-Authorisation Studies (EU PAS) register number, EUPAS22204.

Published
2020

27. Correction to: Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment (Advances in Therapy, (2022), 39, 8, (3501-3521), 10.1007/s12325-022-02166-6)

Author

Oddone, F., Kirwan, J., Lopez-Lopez, F., Zimina, M., Fassari, C., Hollo, G., Faschinger, C., Chen, E., Nemeth, G., Bator, G., Tsorbatzoglou, A., Acs, T., Ferencz, M., Sohajda, Z., Toth, J., Volner, V., Vogt, G., Biro, Z., Facsko, A., Nemes, J., Berta, A., Elek, I., Ng, E., Rossi, G., Rossetti, L., Vetrugno, M., Iester, M., Marchini, G., Scorcia, V., Staurenghi, G., Cagini, C., Salgarello, T., Bettin, P., Figus, M., Scuderi, G. L., De Cilla, S., Grundmane, I., Linavska, N., Volksone, L., Laganovska, G., Baumane, K., Lemij, H., Gundersen, K. G., Erichev, V., Adbulaeva, E., Karlova, E., Zakharova, E., Panova, I., Malyugin, B., Rodriguez-Agirretxe, I., Valladares, A. M., del Castillo, J. B., Gimenez, R., Vallejo, M. P., Garcia-Medina, J. J., Lopez, A. A., Torregrosa, S., Loscos, J., Kolko, M., Ansari, E., Broadway, D., Claridge, K., Ruben, S., Nita, A., Smith, M., Moosavi, A., King, A. J. W., and Kinsella, M.

Subjects
Pharmacology (medical), General Medicine
Abstract

The authors would like to acknowledge missing data for all prior latanoprost users as a whole. The following sentence has been added to the manuscript (page 8, first paragraph): Mean (SD) reduction from baseline at Month 6 for users of all latanoprost formulations (preserved and PF) was 6.1 (4.25) mmHg (25.9%; p\0.0001). The authors have also prepared a table to summarise the change in intraocular pressure following a switch to the preservative-free tafluprost/timolol fixed-dose combination from all latanoprost formulations (preserved and preservative-free formulations). See Table 1 below.(Table Preseneted.) .The original article has been corrected.

Published
2022

28. Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment

Author

Oddone, F., Kirwan, J., Lopez-Lopez, F., Zimina, M., Fassari, C., Hollo, G., Faschinger, C., Chen, E., Nemeth, G., Bator, G., Tsorbatzoglou, A., Acs, T., Ferencz, M., Sohajda, Z., Toth, J., Volner, V., Vogt, G., Biro, Z., Facsko, A., Nemes, J., Berta, A., Elek, I., Ng, E., Rossi, G., Rossetti, L., Vetrugno, M., Iester, M., Marchini, G., Scorcia, V., Staurenghi, G., Cagini, C., Salgarello, T., Bettin, P., Figus, M., Scuderi, G. L., De Cilla, S., Grundmane, I., Linavska, N., Volksone, L., Laganovska, G., Baumane, K., Lemij, H., Gundersen, K. G., Erichev, V., Adbulaeva, E., Karlova, E., Zakharova, E., Panova, I., Malyugin, B., Rodriguez-Agirretxe, I., Valladares, A. M., del Castillo, J. B., Gimenez, R., Vallejo, M. P., Garcia-Medina, J. J., Lopez, A. A., Torregrosa, S., Loscos, J., Kolko, M., Ansari, E., Broadway, D., Claridge, K., Ruben, S., Nita, A., Smith, M., Moosavi, A., King, A. J. W., and Kinsella, M.

Subjects
Adult, Hyperemia, Tafluprost/timolol fixed-dose combination, Ocular hypertension, VISIONARY study, Travoprost, Preservative-free topical medication, Prostaglandin analogue monotherapy, Humans, Pharmacology (medical), Prospective Studies, Chronic, Open-angle glaucoma, Antihypertensive Agents, Intraocular Pressure, Real-world evidence, Prostaglandins A, Fatigue Syndrome, Chronic, Prostaglandins F, Glaucoma, General Medicine, Beta-blocker monotherapy, Fatigue Syndrome, Drug Combinations, Bimatoprost, Open-Angle, Timolol, Latanoprost, Glaucoma, Open-Angle
Abstract

Introduction: The VISIONARY study demonstrated statistically significant intraocular pressure (IOP) reductions with the preservative-free fixed-dose combination of tafluprost 0.0015% and timolol 0.5% (PF tafluprost/timolol FC) in open-angle glaucoma (OAG) or ocular hypertension (OHT) patients, sub-optimally controlled with topical prostaglandin analogue (PGA) or beta-blocker monotherapy. Current subanalyses have examined these data according to the baseline monotherapy. Methods: A European, prospective, observational study included adults (aged ≥ 18 years) with OAG or OHT, who were switched to the PF tafluprost/timolol FC from PGA or beta-blocker monotherapy. Treatment outcomes were reported according to prior monotherapy subgroup: beta-blocker, preserved latanoprost, PF-latanoprost, bimatoprost, tafluprost, and travoprost. Endpoints included the mean change from baseline regarding IOP, conjunctival hyperemia, and corneal fluorescein staining (CFS) at Week 4 and Week 12, and at Month 6. Results: The subanalysis included 577 patients. All prior monotherapy subgroups demonstrated statistically significant IOP reductions from baseline at Week 4, that were maintained through Month 6 (p

Published
2022

31. Contributors

Author

Abdullah, Norazlina, Abed, Nagy Y., Abolhassani, Mehdi, Abu-Rub, Haitham, Abu-Siada, Ahmed, Acero, J., Ahmad, Salman, Ali, Mohammad, Alonso, Jose Marcos, Añó-Villalba, S., Aredes, Maurício, Bal, Güngör, Baniahmed, Salam, Barbosa, Pedro G., Bayhan, Sertac, Bernal-Perez, S., Betz, Robert, Bilhan, Ayse Kocalmis, Blaabjerg, Frede, Blasco-Gimenez, R., Bryant, Angus, Busarello, Tiago Davi Curi, Canacsinh, Hiren, Cheok, Adrian, Chung, Henry Shu-Hung, da Silva Dias, Robson F., de A. Lima, Francisco Kleber, Dillard, William C., Dixon, Juan, Duffy, M.C., Eldali, Fathalla, Farnell, Chris, Gachovska, Tanya K., Giesselmann, Michael, Govindrasu, Manimaran, Hamidi, Seyed Ahmad, Hao, Lei, Hudgins, Jerry L., Hui, Shu Yuen (Ron), Hurley, W.G., Hussien, Zahrul F., Iqbal, Atif, Islam, Syed M., Johnson, Jay, Kabalci, Ersan, Khalid, Muhammad, Khan, M. Rizwan, Khersonsky, Yuri, Kouzou, Abdallah, Krein, Philip T., Krishna, B. Mohan, Kumar, N.B. Shanthi, Lai, Yuk M., Lima Barcelos, Silvangela L.S., Liu, Yunting, Madichetty, Sreedhar, Mantooth, H. Alan, Martínez-Turégano, J., Mazumder, Sudip K., Moinoddin, Shaikh, Morán, Luis, Mude, Kishore Naik, Nasiri, Adel, Niazi, Peyman, Ofoli, Abdul R., Öncü, Selim, Palmer, Patrick, Patterson, Dean, Peng, Kang, Pinto, Sónia F., Pomilio, José Antenor, Rahim, Azlan A., Rahman, Muhammed F., Rashid, Muhammad H., Redondo, Luis, Samanta, Eshan, Sangwongwanich, Ariya, Santi, Enrico, Sarwar, Adil, Sarwat, Arif I., Seo, Gab-Su, Shadmand, Mohammad, Shakweh, Yahya, Shi, Xiaojie, Silva, José Fernando, Simões, Marcelo Godoy, Sood, Vijay K., Tariq, Mohd, Tian, Bo, Tolbert, Leon M., Toliyat, Hamid A., Torres, Miguel, Trzynadlowski, Andrzej M., Ünal, Kenan, Vaquero, Joaquín, Vázquez, Jeziel, Vázquez, Nimrod, Wang, Huai, Watanabe, Edson H., Wilson, Peter R., Yang, Yongheng, and Yuvarajan, Subbaraya

Published
2024
Full Text
View/download PDF

36. Insect and other pests of poplars and willows.

Author

Charles, J. G., primary, Nef, L., additional, Allegro, G., additional, Collins, C. M., additional, Delplanque, A., additional, Gimenez, R., additional, Höglund, S., additional, Jiafu, H., additional, Larsson, S., additional, Luo, Y., additional, Parra, P., additional, Singh, A. P., additional, Volney, W. J. A., additional, and Augustin, S., additional

Published
2014
Full Text
View/download PDF

39. Correction to: Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: The VISIONARY Study (Advances in Therapy, (2020), 37, 4, (1436-1451), 10.1007/s12325-020-01239-8)

Author

Oddone, F., Tanga, L., Kothy, P., Hollo, G., Faschinger, C., Chen, E., Nemeth, G., Bator, G., Tsorbatzoglou, A., Acs, T., Ferencz, M., Sohajda, Z., Toth, J., Volner, V., Vogt, G., Biro, Z., Facsko, A., Nemes, J., Berta, A., Elek, I., Ng, E., Rossi, G., Rossetti, L., Vetrugno, M., Iester, M., Marchini, G., Scorcia, V., Staurenghi, G., Cagini, C., Salgarello, T., Bettin, P., Figus, M., Scuderi, G. L., De Cilla, S., Grundmane, I., Linavska, N., Volksone, L., Laganovska, G., Baumane, K., Lemij, H., Gundersen, K. G., Zimina, M., Erichev, V., Karlova, E., Zakharova, E., Panova, I., Malyugin, B., Aguirrec, I. R., Lopez-Lopez, F., Valladares, A. M., del Castillo, J. B., Gimenez, R., Vallejo, M. P., Garcia-Medina, J. J., Lopez, A. A., Torregrosa, S., Loscos, J., Kolko, M., Ansari, E., Broadway, D., Claridge, K., Ruben, S., Kirwan, J., Nita, A., Smith, M., Moosavi, A., King, A. J. W., and Kinsella, M.

Published
2020

42. Ascorbic acid in diet supplements: loss in the manufacturing process and storage

Author

Gimenez, R., Cabrera, C., Olalla, M., Ruiz, M.D., and Lopez, M.C.

Subjects
Vitamin C -- Production processes, Dietary supplements -- Evaluation, Dietary supplements -- Production processes, Food/cooking/nutrition
Abstract

The ascorbic acid content was determined in 25 different diet supplements commercially available to the consumer in two pharmaceutical forms (pills and ampoules). These products are widely consumed by several population groups (elderly people, sportsmen, adolescents, children, etc.). High-performance liquid chromatography was used as the analytical technique. The proposed method has been validated with good linearity, reproducibility, recovery and accuracy, and can be used in routine analyses and in quality control. The ascorbic acid content in pills ranged from 15.62 to 50.16mg/g, and in that ampoules from 2.12 to 8.83 mg/ml. Depending on the dosage rates, these levels would represent approximately 20-50% of the daily dietary intake recommended by the National Research Council. Possible losses in the manufacturing process and stability during storage for 30 days at 40 [+ or -] 2[degrees]C without light, were tested. In relation to the ascorbic acid concentrations stated on the labels, a loss of 12.0-21.9% in pills and of 11.7-18.0% in ampoules was detected. In relation to the stability conditions, the losses are of 1.8-24.8% in pills and of 10.4-19.3% in ampoules. The pasteurisation and sterilisation processes produced a mean loss of ascorbic acid in ampoules of 2.1 and 1.4%, respectively. A statistically significant direct correlation was observed between ascorbic acid loss and content in proteins, humidity, ash, and fructose. The influence of the pharmaceutical form was also tested. Data revealed that the control of losses during the manufacturing and commercialisation process of these products is necessary to ensure the intake of vitamin C from these products by the consumer.

Published
2002

44. Abstracts of papers presented at the 81st annual meeting of The Potato Association of America Charlottetown, P.E.I., Canada August 3 – 7, 1997

Author

Ali-Khan S. T., Hetner, C., Ladislav, L., Currie, V., Arsenault Walter J., Aziz A. Naseer, Seabrook, Janet E. A., Tai, George C. C., Bamberg J. B., del Rio, Alfonso H., Martin, Max, Bamberg J. B., Ormrod, D. J., Fry, W. E., Barrett K. B., Nolte, P., Jones, W. B., Bateman, M. A., Bertram, M. C., Nolte, L. L., Bertram Melissa C., Ojala, John, Barrall, Geoffrey A., Blankemeyer James T., McWilliams, Misty L., Friedman, Mendel, Boiteau Gilles, Boluarte Tatiana, Veilleux, Richard E., Brown C. R., Schuck-Ennis, B., Yang, C. P., Mojtahedi, H., Santo, G. S., Cambouris Athyna N., Nolin, Michel C., Simard, Régis R., Cani Eduard, Ashkenazi, Varda, Hillel, Jossi, Veilleux, Richard E., Cappaert M. R., Powelson, M. L., Inglis, D. I., Cappaert M. R., Powelson, M. L., Chen Yu-Kuang, Bamberg, John B., Palta, Jiwan P., Christ B. J., Haynes, K. G., Coltman Robert R., German, Thomas L., Corsini Dennis, Kleinkopf, Gale, Brandt, Tina, Outright Rebecca, Veilleux, Richard E., Dan H., Stankiewicz, A., Ali-Khan, S. T., Robb, J., Davidson Robert D., Douches D. S., Kirk, W. W., Bamberg, J. B., Edwards Linnell M., Emery Suzanne M., Halseth, Donald E., Ewing Elmer E., Simko, Ivan, Davies, Peter J., Fernando Sydney, McMorran, Jeffrey, Mosley, Alvin, Clough, George, Finnan David, Allen, Eric, Fitzgerald Caragh B., Porter, Gregory A., Erich, M. Susan, Goth R. W., Haynes, K. G., Grafius E. J., Mota-Sanchez, D., Bishop, B. A., Whalon, M. E., Groza Horia, Bowen, Bryan, Jiang, Jiming, Groza Horia, Coltman, Robert, Gunter Christopher C., Palta, Jiwan P., Gunter Christopher C., Palta, Jiwan P., Hamernik A. J., Hanneman, R. E., Hamm Philip B., Ingham, Russell E., Jaeger, Joy R., Hanneman R. E., Haynes K. G., Lambert, D. H., Christ, B. J., Weingartner, D. P., Douches, D. S., Backlund, J. E., Secor, G., Fry, W., Stevenson, W., Helgeson J. P., Haberlach, G. T., McGrath, J. M., Raasch, J. A., Naess, S. K., Wielgus, S. M., Hernández A., Lozoya-Saldaña, H., Zavala, T., Honess Brian L., Tai, George C. C., Honeycutt C. Wayne, Hughes Becky R., Keith, Candy N. F., Inglis D. A., Gundersen, B., Powelson, M. L., Cappaert, M. R., Inglis D., Gundersen, B., Thornton, R., Jansky Shelley, Rouse, Doug, Johnson Alexander, Piovano, Suzanne, Ravichandran, Vidya, Teparkum, Sirasak, Chani, Eduard, Veilleux, Richard E., Jones W. B., Hempstead, D. W., Scott, J. B., Kalt Willy, Prange, Robert, Daniels-Lake, Barbara, Walsh, John, Dean, Paul, Coffin, Robert, Page, Robyne, Kawchuk L. M., DeJong, H., Burns, V. J., Kimpinski J., Platt, H. W., Kirk William, Niemira, Brendan A., Kitchen, Brian, Stein, Jeffery, Hammerschmidt, Raymond, Kowalski Stanley P., Domek, John M., Perez, Frances G., Sanford, Lind L., Deahl, Kenneth L., Kowalski Stanley P., Yencho, G. Craig, Kobayashi, Ruth S., Perez, Frances G., Sinden, Stephen L., Deahl, Kenneth L., Laird David W., Bassi, Albert B., Tally, Allison, Lambert Dave, Currier, Ann, Olanya, Modesto, Li W., Douches, D. S., Pett, W., Coombs, J., Zarka, K., Grafius, E., Loria Rosemary, Fry, Barbara A., Bukhalid, Raghida A., Grace, Elizabeth A., Langille Alan R., Lan, Yu, Reeves, A. F., Love Stephen L., Werner, Bruce K., Pavek, Joseph J., Lozoya-Saldaña H., Hernãndez, A., Lozova-Saldaña H., Hern↭dez, A., Flores, R., Bamberg, J., Ludy R. L., Powelson, M. L., Lulai Edward C., Klinge, Manrique, Kurt Stephen L. Lovev, Brown, Jack, Marco Medina, Platt, H. W., Peters, R. D., McBeath Jenifer Huang, Miller J., Creighton Douglas C., Scheuring Jeannine P. Millerv, Fernandez, George C. J., Mills Dallice, Russell, Brian W., Mozafari J., Wolyn, D. J., Ali-Khan, S. T., Mpofu S. I., Hall, R., Mundy C., Creamer, N. G., Crozier, C. R., Morse, R. D., Newberry George, Thornton, Robert, Niemira Brendan A., Kirk, William, Douches, David, Hammerschmidt, Raymond, Nolte P., Thornton, M. K., Love, S. L., Berger, P. H., Whitworth, J. L., Davidson, R., Novy Richard, Longtine, Craig, Etuberosum, Solanum, Olivier Claudia, Mizubuti, Eduardo S. G., Halseth, Donald E., Loria, Rosemary, Olsen Nora L., Thornton, Robert E., Parks R. L., Powelson, M. L., Cappaert, M. R., Johnson, K. B., Pavek Joseph J., Corsini, Dennis L., Pavuluri Sridevi, Freeman, T. P., Baer, D., Gudmestad, N. C., Pelletier Yvan, Peralta Iris E., Ballard, Harvey, Spooner, David M., Peters R. D., Platt, H. W. (Bud), Hall, Robert, Driscoll, A., MacPhail, A., Jenkins, S., Connors, E., Medina, M., MacLean, V., Philip Maxwell, Platt, H. W., Nazar, R., Robb, J., MacLean, V., Pineda Omaira, Plaisted, Robert L., Tanksley, Steven D., Pineda Omaira, Plaisted, Robert L., Tanksley, Steven D., Platt H. W., Medina, M., Perley, S., Walsh, J., Porter Gregory A., Sisson, Jonathan A., Porter Gregory A., Sisson, Jonathan A., Power R. J., Hamlen, R. A., Gimenez, R. M., Iruegas, R., Prange Robert, Kalt, Willy, Daniels-Lake, Barbara, Liew, Chiam, Walsh, John, Dean, Paul, Coffin, Robert, Page, Robyne, Ramon M., Serquen, Felix C., Hanneman, R. E., Riggle Bruce, Schafer, Ron, del Rio Alfonso H., Bamberg, J. B., Romain R., Lambert, R., Michaud, R., Lapointe, C., Ronning Catherine M., Sanford, Lind L., Stommel, John R., Perez, Frances G., Deahl, Kenneth L., Sanderson J. Brian, Carter, M. R., Johnston, H. W., Holmstrom, D. A., Sanford L. L., Kowalski, S., Deahl, K. L., Ronning, C., Schisler D. A., Kleinkopf, G., Slininger, P. J., Bothast, R. J., Ostrowski, R. C., Seabrook Janet E. A., Douglass, L. Katheryn, Sedegui Mohamed, R. B., Carroll A. L. Morehart, Whittington, D. P., Mullroony, R. P., Serquen Felix C., Hanneman, Robert E., Simard Régis R., Cambouris, Athyna, Lafond, Jean, Tyouss, A., Singh Mathuresh, Singh, Rudra P., Singh Rudra P., Slininger P. J., Schisler, D. A., Burkhead, K. D., Ostrowski, R. C., Bothast, R. J., Song Junqi, Jiang, Jiming, Souza-Dias Jose A., de Caram P. Russo, Betti, J. A., Miller, L., Slack, S. A., Souza-Dias Jose A., de Caram, Tristao, J. F., Sowokinos Joseph R., Stalham Mark, Rosenfeld, Anton, Stewart Jeff, Sturz Antony V., Matheson, Brian G., Teparkum Sirasak, Veilleux, Richard E., Thompson-Johns Asunta, Davidson, Robert D., Timm George H., Thornton, Robert E., Van Hest Peter, van der Merwe, J. J., Vayda Michael E., Morelli, James K., Englehart, Kathryn M., Vega Sandra E., Bamberg, John B., Palta, Jiwan P., Walsh John, Peterson, R. Larry, Melville, Lewis, Wang L., Pritchard, M. K., Wang L., Pritchard, M. K., Westedt A., Douches, D. S., Grafius, E., Westermann D. T., Davis, J. R., Everson, D. O., Work Richard W., Work, T. M., Bushway, A. A., Work Therese M., Reeves, Alvin A., Yu Wan-Chin, Joyce, Peter J., Cameron, Douglas C., McCown, Brent H., and Veilleux, Richard E.

Published
1997
Full Text
View/download PDF

45. Extracellular vesicles and soluble factors secreted by Escherichia coli Nissle 1917 and ECOR63 protect against enteropathogenic E. coli-induced intestinal epithelial barrier dysfunction

Author

Alvarez CS, Gimenez R, Canas MA, Vera R, Díaz-Garrido N, Badia J, and Baldoma L

Subjects
Outer membrane vesicles, Tight junctions, ECOR63, EPEC, Escherichia coli Nissle 1917, Intestinal epithelial barrier, digestive system
Abstract

BACKGROUND: Enteric pathogens have developed mechanisms to disrupt tight junctions and increase gut permeability. Many studies have analysed the ability of live probiotics to protect intestinal epithelial cells against tight junction damage caused by bacterial pathogens. Escherichia coli Nissle 1917 (EcN) is among the probiotics that positively modulates the intestinal epithelial barrier by regulating expression and distribution of tight junction proteins. We previously reported that regulation of ZO-1, claudin-14 and claudin-2 is mediated by EcN secreted factors, either free-released or associated with outer membrane vesicles (OMVs). Factors secreted by commensal ECOR63 elicited comparable effects in intact epithelial T-84 and Caco-2 cell monolayers. RESULTS: Here we analyse the ability of OMVs and soluble secreted factors to protect epithelial barrier function in polarized T-84 and Caco-2 cells infected with enteropathogenic Escherichia coli (EPEC). Transepithelial electrical resistance, paracellular permeability, mRNA levels and subcellular distribution of tight junction proteins were monitored in the absence or presence of EcN and ECOR63 extracellular fractions. EPEC downregulated expression of ZO-1 ZO-2, occludin and claudin-14 and altered the subcellular localization of ZO-1, occludin and F-actin cytoskeleton. OMVs and soluble factors secreted by EcN and ECOR63 counteracted EPEC-altered transepithelial resistance and paracellular permeability, preserved occludin and claudin-14 mRNA levels, retained ZO-1 and occludin at tight junctions in the cell boundaries and ameliorated F-actin disorganization. Redistribution of ZO-1 was not accompanied by changes at mRNA level. CONCLUSION: This study provides new insights on the role of microbiota secreted factors on the modulation of intestinal tight junctions, expanding their barrier-protective effects against pathogen-induced disruption.

Published
2019

47. Outer Membrane Vesicles From Probiotic and Commensal Escherichia coli Activate NOD1-Mediated Immune Responses in Intestinal Epithelial Cells

Author

Canas MA, Fabrega MJ, Gimenez R, Badia J, and Baldoma L

Subjects
body regions, NOD1, gut microbiota, bacterial extracellular vesicles, NF-?B activation, Escherichia coli Nissle 1917
Abstract

Gut microbiota plays a critical role in maintaining human intestinal homeostasis and host health. Bacterial extracellular vesicles are key players in bacteria-host communication, as they allow delivery of effector molecules into the host cells. Outer membrane vesicles (OMVs) released by Gram-negative bacteria carry many ligands of pattern recognition receptors that are key components of innate immunity. NOD1 and NOD2 cytosolic receptors specifically recognize peptidoglycans present within the bacterial cell wall. These intracellular immune receptors are essential in host defense against bacterial infections and in the regulation of inflammatory responses. Recent contributions show that NODs are also fundamental to maintain intestinal homeostasis and microbiota balance. Peptidoglycan from non-invasive pathogens is delivered to cytosolic NODs through OMVs, which are internalized via endocytosis. Whether this pathway could be used by microbiota to activate NOD receptors remains unexplored. Here, we report that OMVs isolated from the probiotic Escherichia coli Nissle 1917 and the commensal ECOR12 activate NOD1 signaling pathways in intestinal epithelial cells. NOD1 silencing and RIP2 inhibition significantly abolished OMV-mediated activation of NF-?B and subsequent IL-6 and IL-8 expression. Confocal fluorescence microscopy analysis confirmed that endocytosed OMVs colocalize with NOD1, trigger the formation of NOD1 aggregates, and promote NOD1 association with early endosomes. This study shows for the first time the activation of NOD1-signaling pathways by extracellular vesicles released by gut microbiota.

Published
2018

48. Review and update on non-suicidal self-injury: who, how and why?

Author

Vega, D, Sintes, A, Fernandez, M, Punti, J, Soler, J, Santamarina, P, Soto, A, Lara, A, Mendez, I, Martinez-Gimenez, R, Romero, S, and Pascual, JC

Subjects
Suicide, Non-suicidal self-injury, Self-harm, Review
Abstract

Non-suicidal self-injury (NSSI) is defined as the direct and deliberate destruction of one's own body tissue in the absence of lethal intent. Following decades of progressive increase in the incidence of NSSI among adolescents and young adults, as well as growing scientific interest, the disorder was listed as a condition for further study in the Diagnostic and Statistical Manual of Mental Disorders (fifth edition). In this review we provide updated information on this phenomenon, focusing on: prevalence, course and prognosis; associated factors; its relationship with psychopathology; and the role of the mass media, social networks, and the internet. Finally, we discuss some conclusions and future proposals, emphasizing the need for collaborative work to better understand NSSI in Spain, and to improve prevention and treatment strategies.

Published
2018

Catalog

Books, media, physical & digital resources
See catalog results